Investigational diabetes drug from controversial class shows promiseBut Japanese patient population that was the subject of this study has different risk factors compared with other groups New antiretroviral agent added to HIV arsenal 2011 Eye Care Supplement: Keeping an eye on cataracts Prevention, treatment and patient education. Edurant: a new NNRTI for HIV Rilpivirine is the fifth NNRTI to be marketed in Canada. Once-weekly exenatide no match for daily liraglutide in type 2 diabetes HbA1c lowering less than expected, but researchers note side-effect profile and injection frequency are attractive features P.E.I. pharmacists in anti-smoking campaign Pharmacists’ association, Cancer Society link up for six-week anti-smoking campaign. 2011 Eye Care Supplement: Eye Infections Current management strategies and key counselling tips. Tighten control of opioids, ICES urges Author drafting new guidelines doubts restrictions, including on opioids marketing, would reduce diversion New diabetes drug class may be good for the heart Despite initial worries, gliptins demonstrate cardioprotective effects Guidelines issued on pediatric pneumonia Canadian, U.S. groups recommend amoxicillin as first-line therapy over cephalosporins and macrolides First Previous 1034 1035 1036 1037 1038 Next Last
